Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-19-002163

Chief Financial Officer sold 3,084 shares at $5.37 ($16,559)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Rawcliffe Adrian Chief Financial Officer 2019-01-14 Sale −3,084 $5.37 $16,559 3,318 D
Open-market sales · 3,084 sh · avg $5.37 · $16,559
Loading xslF345X03/a4.xml…